BSE Live
Dec 26, 16:01Prev. Close
5563.80
Open Price
5563.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:56Prev. Close
5566.00
Open Price
5539.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5535.00 (39)
| Key Financial Ratios of Alkem Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 105.75 | 66.90 | 59.87 | 73.86 | 58.56 | |
| Diluted EPS (Rs.) | 105.75 | 66.90 | 59.87 | 73.86 | 58.56 | |
| Cash EPS (Rs.) | 121.39 | 78.70 | 68.88 | 80.27 | 64.72 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 525.34 | 457.15 | 408.65 | 367.43 | 301.09 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 525.34 | 457.15 | 408.65 | 367.43 | 301.09 | |
| Dividend / Share(Rs.) | 25.00 | 16.00 | 13.00 | 15.00 | 12.70 | |
| Revenue from Operations/Share (Rs.) | 558.52 | 477.97 | 443.35 | 390.50 | 330.49 | |
| PBDIT/Share (Rs.) | 130.79 | 93.12 | 89.86 | 83.19 | 81.23 | |
| PBIT/Share (Rs.) | 115.16 | 81.32 | 80.86 | 76.80 | 75.07 | |
| PBT/Share (Rs.) | 111.93 | 78.96 | 78.15 | 74.82 | 70.17 | |
| Net Profit/Share (Rs.) | 105.76 | 66.90 | 59.88 | 73.87 | 58.57 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.41 | 19.48 | 20.26 | 21.30 | 24.57 | |
| PBIT Margin (%) | 20.61 | 17.01 | 18.23 | 19.66 | 22.71 | |
| PBT Margin (%) | 20.03 | 16.51 | 17.62 | 19.15 | 21.23 | |
| Net Profit Margin (%) | 18.93 | 13.99 | 13.50 | 18.91 | 17.72 | |
| Return on Networth / Equity (%) | 20.13 | 14.63 | 14.65 | 20.10 | 19.45 | |
| Return on Capital Employed (%) | 21.09 | 17.29 | 19.22 | 20.47 | 24.46 | |
| Return on Assets (%) | 13.88 | 10.96 | 10.50 | 14.97 | 14.51 | |
| Total Debt/Equity (X) | 0.19 | 0.09 | 0.11 | 0.08 | 0.10 | |
| Asset Turnover Ratio (%) | 73.32 | 78.35 | 77.78 | 79.14 | 81.93 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.64 | 1.84 | 1.64 | 1.60 | 1.80 | |
| Quick Ratio (X) | 1.22 | 1.25 | 1.07 | 1.00 | 1.29 | |
| Inventory Turnover Ratio (X) | 6.11 | 5.76 | 5.18 | 5.44 | 6.70 | |
| Dividend Payout Ratio (NP) (%) | 28.36 | 22.42 | 25.05 | 8.12 | 21.68 | |
| Dividend Payout Ratio (CP) (%) | 24.71 | 19.06 | 21.77 | 7.47 | 19.62 | |
| Earnings Retention Ratio (%) | 71.64 | 77.58 | 74.95 | 91.88 | 78.32 | |
| Cash Earnings Retention Ratio (%) | 75.29 | 80.94 | 78.23 | 92.53 | 80.38 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 28,285.17 | 21,047.79 | 23,904.26 | 26,553.26 | 16,163.10 | |
| EV/Net Operating Revenue (X) | 4.24 | 3.68 | 4.51 | 5.69 | 4.09 | |
| EV/EBITDA (X) | 18.09 | 18.91 | 22.25 | 26.70 | 16.64 | |
| MarketCap/Net Operating Revenue (X) | 4.17 | 3.67 | 4.46 | 5.65 | 4.13 | |
| Retention Ratios (%) | 71.63 | 77.57 | 74.94 | 91.87 | 78.31 | |
| Price/BV (X) | 4.43 | 3.83 | 4.84 | 6.01 | 4.54 | |
| Price/Net Operating Revenue | 4.17 | 3.67 | 4.46 | 5.65 | 4.13 | |
| Earnings Yield | 0.05 | 0.04 | 0.03 | 0.03 | 0.04 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key